相关实验视频

Updated: Jun 15, 2025

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

慢性鼻炎与鼻息肉 (CRSwNP) 的弗卢蒂卡松 propionate:一个人工智能驱动的共识共识

Emilio Avallone¹, Raffaella Iannella¹, Antonella Di Lullo¹

¹Department of Otolaryngology, AORN "San Pio", Benevento, Italy.

Frontiers in allergy

|June 13, 2025

概括

酸可有效治疗具有鼻多重症 (CRSwNP) 的慢性鼻炎,减少手术需要和多重症复发. 先进的输送系统提高了治疗结果和患者的生活质量.

科学领域:

耳鼻喉科耳鼻喉科耳鼻喉科
药理学药理学是指药理学的学科.
人工智能的人工智能

背景情况:

氨酸 (FP) 是一种局部皮质类固醇,用于治疗具有鼻多重症 (CRSwNP) 的慢性鼻炎.
优化局部治疗对于改善临床结果和最大限度地减少CRSwNP治疗的全身副作用至关重要.
需要在CRSwNP管理中对FP的最佳使用方面达成专家共识.

研究的目的:

建立一个专家的共识,在使用酸 (FP) 治疗CRSwNP.
评估FP在管理CRSwNP症状和复发方面的有效性.
评估先进传递系统在增强CRSwNP的FP治疗中的作用.

主要方法:

通过使用蝶决策人工智能平台促进了专家的共识.
该平台收集并整合了有关FP使用的13个关键陈述的专家评估和反.
参与者在建立的陈述上达成了高度一致.

主要成果:

专家们达成了强烈的共识,即FP有效地减少了CRSwNP患者手术的需要.
在控制CRSwNP症状和改善患者的生活质量方面,FP治疗非常有效.
先进的输送系统显著改善了药物输送,治疗结果,并减少了鼻息肉复发.

结论:

酸是CRSwNP的第一线局部治疗方法,因为它的有效性和低系统生物可用性.
蝶决策人工智能平台通过透明和客观的评估证明了临床决策的有效性.
优化的FP治疗,特别是先进的输送系统,为CRSwNP患者提供了显著的好处.

关键词:

在CRSwNP中使用.蝶蝶蝶蝶蝶一致的共识共识.这种药物是fluticasone.鼻液是指鼻子上的滴水.

更多相关视频

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

相关概念视频

Drugs Used in Upper Respiratory Disorders: Overview

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...